The main call I'd make about results like this - which those wanting to promote pointless drama of course won't, is:
i) safety was not an issue.
2) the trial result was based on a SINGLE application, over a relatively short time frame! For a serious chronic condition??? Really??? A SINGLE application, measured over a short time frame?? I really don't know how they produce a result any "professional" could draw a serious conclusion from!
fda study unprecedented !, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.018(1.60%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.07 | $1.003M | 928.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 71327 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 66570 | 11 |
View Market Depth
| Last trade - 10.44am 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |